Nissen, M J; Ciurea, A; Bernhard, J; Tamborrini, G; Mueller, R; Weiss, B; Toniolo, M; Exer, P; Finckh, A (2016). The effect of comedication with a conventional synthetic disease-modifying antirheumatic drug on drug retention and clinical effectiveness of anti-tumor necrosis factor therapy in patients with axial spondyloarthritis. Arthritis and Rheumatology, 68(9):2141-2150.
Wueest, S; Mueller, R; Blüher, M; Item, F; Chin, A S; Wiedemann, M S; Takizawa, H; Kovtonyuk, L; Chervonsky, A V; Schoenle, E J; Manz, M G; Konrad, D (2014). Fas (CD95) expression in myeloid cells promotes obesity-induced muscle insulin resistance. EMBO Molecular Medicine, 6(1):43-56.
Favrot, C; Linek, M; Mueller, R; Zini, E (2010). Development of a questionnaire to assess the impact of atopic dermatitis on health-related quality of life of affected dogs and their owners. Veterinary Dermatology, 21(1):63-69.
Olivry, T; Mueller, R; Nuttall, T; Favrot, C; Prélaud, P (2008). Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis. Veterinary Dermatology, 19(3):115-119.